Picking Nits or Learning Lessons?
By Marcy Darnovsky and Osagie K. Obasogie,
Bioethics Forum
| 09. 17. 2007
Defensiveness on Display in Gene Therapy Death
The full story of 36-year-old Jolee Mohr's recent death in a gene therapy clinical trial for rheumatoid arthritis is still unfolding. The study, sponsored by Seattle-based Targeted Genetics, remains on hold. A team of 20 doctors and scientists at the University of Chicago Medical Center has combed through autopsy samples. The FDA has yet to announce the direct cause of death, and the Recombinant DNA Advisory Committee (RAC) will discuss the case at its September 17 meeting.
There's a lot we don't yet know. But there's a fair amount we do know, and much of it is troubling. Gene therapy's high public profile has led journalists to investigate information released by Mohr's family that raises questions about the study's design, inclusion criteria, and conduct. Some are specific to the Targeted Genetics study while others are broader. Even if no one had died, a number of these issues would still be quite relevant given gene therapy's record to date: inconclusive at best, and certainly disappointing given the high hopes repeated over two decades.
One key concern is whether people whose...
Related Articles
By Fyodor Urnov, Time | 08.12.2024
After a lifetime in the field of epigenetics, and nearly 20 years after my colleagues and I coined the term “genome editing,” I will be the first to admit that describing the “epigenome”—a marvelous biological process that guides...
By Joy Zhang, Progress Educational Trust | 08.12.2024
What do China's new ethical guidlines tell us about the country's changing attitude to human genome editing? Professor Joy Zhang reads between the lines...
Recently, China's National Science and Technology Ethics Committee introduced a new set of ethics guidelines on...
By Émile P. Torres, Truthdig | 08.08.2024
By Priyanka Runwal, Chemical and Engineering News | 08.05.2024
Saritee Sanodiya, 26, has spent countless days wondering if she’ll ever live a “normal” life. Growing up, Sanodiya often missed school, frequenting the hospital for sudden, life-threatening drops in her hemoglobin levels and excruciating pain in her joints. High fever...